Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript
Start Time: 16:30 End Time: 17:02 Acorda Therapeutics, Inc.
Source: seekingalpha.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Acorda Grant Program. Real-time updates on events, politics, business and more.